Bendamustine Dimer 2-Allyl Ester

Bendamustine Dimer 2-Allyl Ester or 4-(5-((2-((4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate allyl ester chemical group organic compound is associate impurity of Bendamustine. Bendamustine may be a therapy medication utilized in the treatment of chronic leukemia (CLL), myeloma, and non-Hodgkin’s malignant neoplastic disease.

Additional information

Catalogue No.

VE007308

CAS No.

N/A

Molecular Formula

C35H45Cl3N6O4

Molecular Weight

720.13 g/mol

IUPAC Name

4-(5-((2-((4-(5-(Bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoyl)oxy)ethyl)(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate allyl ester

References

“Sci-Hub, Determination and Characterization of Two Degradant Impurities in Bendamustine Hydrochloride Drug Product, 10.1093/Chromsci/Bmv070.” Hkvisa.net, 2015, sci-hub.hkvisa.net/10.1093/chromsci/bmv070.

Status

In-stock